- Home
- AMWD vs ELVN Comparison
AMWD vs ELVN Comparison
Compare AMWD & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMWD
- ELVN
- Stock Information
- Founded
- AMWD 1980
- ELVN 2016
- Country
- AMWD United States
- ELVN United States
- Employees
- AMWD N/A
- ELVN N/A
- Industry
- AMWD Forest Products
- ELVN Biotechnology: Pharmaceutical Preparations
- Sector
- AMWD Basic Materials
- ELVN Health Care
- Exchange
- AMWD Nasdaq
- ELVN Nasdaq
- Market Cap
- AMWD 760.7M
- ELVN 927.8M
- IPO Year
- AMWD N/A
- ELVN 2020
- Fundamental
- Price
- AMWD $56.61
- ELVN $20.73
- Analyst Decision
- AMWD Buy
- ELVN Strong Buy
- Analyst Count
- AMWD 4
- ELVN 5
- Target Price
- AMWD $83.33
- ELVN $41.20
- AVG Volume (30 Days)
- AMWD 167.4K
- ELVN 747.2K
- Earning Date
- AMWD 08-26-2025
- ELVN 08-12-2025
- Dividend Yield
- AMWD N/A
- ELVN N/A
- EPS Growth
- AMWD N/A
- ELVN N/A
- EPS
- AMWD 6.50
- ELVN N/A
- Revenue
- AMWD $1,709,585,000.00
- ELVN N/A
- Revenue This Year
- AMWD N/A
- ELVN N/A
- Revenue Next Year
- AMWD $4.03
- ELVN N/A
- P/E Ratio
- AMWD $8.71
- ELVN N/A
- Revenue Growth
- AMWD N/A
- ELVN N/A
- 52 Week Low
- AMWD $50.00
- ELVN $13.30
- 52 Week High
- AMWD $106.57
- ELVN $30.03
- Technical
- Relative Strength Index (RSI)
- AMWD 57.06
- ELVN 52.08
- Support Level
- AMWD $50.00
- ELVN $19.22
- Resistance Level
- AMWD $57.58
- ELVN $21.90
- Average True Range (ATR)
- AMWD 2.43
- ELVN 1.49
- MACD
- AMWD 0.72
- ELVN -0.19
- Stochastic Oscillator
- AMWD 83.99
- ELVN 39.43
About AMWD American Woodmark Corporation
American Woodmark Corp manufactures and distributes cabinets and vanities for the remodeling and new home construction markets. It offers several products that fall into product lines including kitchen cabinetry, bath cabinetry, office cabinetry, home organization, and hardware. The products are sold under the brand names American Woodmark, Timberlake, Shenandoah Cabinetry, and Waypoint Living Spaces among others.
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.